A Phase II Study of Chemotherapy Combined with Tyrosine Kinase Inhibitors for Children with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (JPLSG ALL-Ph13).
Not Applicable
Recruiting
- Conditions
- Childhood Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
- Registration Number
- JPRN-UMIN000011946
- Lead Sponsor
- Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 44
Inclusion Criteria
Not provided
Exclusion Criteria
1) uncontrolled infection, including active tuberculosis and positive of HIV antibody. 2) pregnancy or high possibility of pregnancy and giving suck wiman. 3) history of congenital or acquired immunodeficiency. 4) any inappropriate status judged by physician.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Three years event free survival
- Secondary Outcome Measures
Name Time Method